ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 806,21
-0,14%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Humacyte Inc (HUMA)

  7. Humacyte Inc (HUMA) Actualités

HUMA Humacyte Inc

4,45
0,05 (1,14%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Humacyte Inc HUMA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 1,14% 4,45 06:00:09
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,50 4,36 4,57 4,41 4,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/3/202422:03EDGAR2Form SC 13D/A - General statement of acquisition of..
04/3/202412:53EDGAR2Form 8-K - Current report
29/2/202422:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:02EDGAR2Form 8-K - Current report
09/2/202414:06EDGAR2Form 8-K - Current report
12/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202314:06EDGAR2Form 8-K - Current report
09/11/202322:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:07EDGAR2Form 8-K - Current report
10/10/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:09EDGAR2Form SC 13D/A - General statement of acquisition of..
15/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202313:09EDGAR2Form 8-K - Current report
12/9/202302:03DJNStocks to Watch: Oracle, Acelyrin, Humacyte
22/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:28EDGAR2Form 144 - Report of proposed sale of securities
14/8/202314:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:05EDGAR2Form 8-K - Current report
31/7/202319:28DJNHumacyte Shares Rise 8% After Completing Enrollment in Phase..
26/7/202314:07EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
HUMA
Humacyte
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés